The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ceftriaxone Sodium Market Research Report 2025
Synopsis
Ceftriaxone sodium is a cephalosporin antibiotic.
The global Ceftriaxone Sodium market was valued at US$ 264.2 million in 2023 and is anticipated to reach US$ 217.6 million by 2030, witnessing a CAGR of -2.7% during the forecast period 2024-2030.
There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.
Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.
For the production, China and India are the mainly manufactured base.
Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.
This report aims to provide a comprehensive presentation of the global market for Ceftriaxone Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ceftriaxone Sodium.
Report Scope
The Ceftriaxone Sodium market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ceftriaxone Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ceftriaxone Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
Kelun
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran
Segment by Type
ChP
USP
EP
Segment by Application
Single Injection
Compound Injection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ceftriaxone Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ceftriaxone Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ceftriaxone sodium is a cephalosporin antibiotic.
The global Ceftriaxone Sodium market was valued at US$ 264.2 million in 2023 and is anticipated to reach US$ 217.6 million by 2030, witnessing a CAGR of -2.7% during the forecast period 2024-2030.
There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.
Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.
For the production, China and India are the mainly manufactured base.
Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.
This report aims to provide a comprehensive presentation of the global market for Ceftriaxone Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ceftriaxone Sodium.
Report Scope
The Ceftriaxone Sodium market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ceftriaxone Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ceftriaxone Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
Kelun
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran
Segment by Type
ChP
USP
EP
Segment by Application
Single Injection
Compound Injection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ceftriaxone Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ceftriaxone Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ceftriaxone Sodium Market Overview
1.1 Product Overview and Scope of Ceftriaxone Sodium
1.2 Ceftriaxone Sodium Segment by Type
1.2.1 Global Ceftriaxone Sodium Market Value Comparison by Type (2024-2030)
1.2.2 ChP
1.2.3 USP
1.2.4 EP
1.3 Ceftriaxone Sodium Segment by Application
1.3.1 Global Ceftriaxone Sodium Market Value by Application: (2024-2030)
1.3.2 Single Injection
1.3.3 Compound Injection
1.4 Global Ceftriaxone Sodium Market Size Estimates and Forecasts
1.4.1 Global Ceftriaxone Sodium Revenue 2019-2030
1.4.2 Global Ceftriaxone Sodium Sales 2019-2030
1.4.3 Global Ceftriaxone Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ceftriaxone Sodium Market Competition by Manufacturers
2.1 Global Ceftriaxone Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ceftriaxone Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ceftriaxone Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Ceftriaxone Sodium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ceftriaxone Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ceftriaxone Sodium, Product Type & Application
2.7 Ceftriaxone Sodium Market Competitive Situation and Trends
2.7.1 Ceftriaxone Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ceftriaxone Sodium Players Market Share by Revenue
2.7.3 Global Ceftriaxone Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ceftriaxone Sodium Retrospective Market Scenario by Region
3.1 Global Ceftriaxone Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ceftriaxone Sodium Global Ceftriaxone Sodium Sales by Region: 2019-2030
3.2.1 Global Ceftriaxone Sodium Sales by Region: 2019-2024
3.2.2 Global Ceftriaxone Sodium Sales by Region: 2025-2030
3.3 Global Ceftriaxone Sodium Global Ceftriaxone Sodium Revenue by Region: 2019-2030
3.3.1 Global Ceftriaxone Sodium Revenue by Region: 2019-2024
3.3.2 Global Ceftriaxone Sodium Revenue by Region: 2025-2030
3.4 North America Ceftriaxone Sodium Market Facts & Figures by Country
3.4.1 North America Ceftriaxone Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ceftriaxone Sodium Sales by Country (2019-2030)
3.4.3 North America Ceftriaxone Sodium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ceftriaxone Sodium Market Facts & Figures by Country
3.5.1 Europe Ceftriaxone Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ceftriaxone Sodium Sales by Country (2019-2030)
3.5.3 Europe Ceftriaxone Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ceftriaxone Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Ceftriaxone Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ceftriaxone Sodium Sales by Country (2019-2030)
3.6.3 Asia Pacific Ceftriaxone Sodium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ceftriaxone Sodium Market Facts & Figures by Country
3.7.1 Latin America Ceftriaxone Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ceftriaxone Sodium Sales by Country (2019-2030)
3.7.3 Latin America Ceftriaxone Sodium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ceftriaxone Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Ceftriaxone Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ceftriaxone Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ceftriaxone Sodium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ceftriaxone Sodium Sales by Type (2019-2030)
4.1.1 Global Ceftriaxone Sodium Sales by Type (2019-2024)
4.1.2 Global Ceftriaxone Sodium Sales by Type (2025-2030)
4.1.3 Global Ceftriaxone Sodium Sales Market Share by Type (2019-2030)
4.2 Global Ceftriaxone Sodium Revenue by Type (2019-2030)
4.2.1 Global Ceftriaxone Sodium Revenue by Type (2019-2024)
4.2.2 Global Ceftriaxone Sodium Revenue by Type (2025-2030)
4.2.3 Global Ceftriaxone Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Ceftriaxone Sodium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ceftriaxone Sodium Sales by Application (2019-2030)
5.1.1 Global Ceftriaxone Sodium Sales by Application (2019-2024)
5.1.2 Global Ceftriaxone Sodium Sales by Application (2025-2030)
5.1.3 Global Ceftriaxone Sodium Sales Market Share by Application (2019-2030)
5.2 Global Ceftriaxone Sodium Revenue by Application (2019-2030)
5.2.1 Global Ceftriaxone Sodium Revenue by Application (2019-2024)
5.2.2 Global Ceftriaxone Sodium Revenue by Application (2025-2030)
5.2.3 Global Ceftriaxone Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Ceftriaxone Sodium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shandong Ruiying
6.1.1 Shandong Ruiying Corporation Information
6.1.2 Shandong Ruiying Description and Business Overview
6.1.3 Shandong Ruiying Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shandong Ruiying Ceftriaxone Sodium Product Portfolio
6.1.5 Shandong Ruiying Recent Developments/Updates
6.2 Qilu Antibiotics
6.2.1 Qilu Antibiotics Corporation Information
6.2.2 Qilu Antibiotics Description and Business Overview
6.2.3 Qilu Antibiotics Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Qilu Antibiotics Ceftriaxone Sodium Product Portfolio
6.2.5 Qilu Antibiotics Recent Developments/Updates
6.3 Nectar Lifesciences
6.3.1 Nectar Lifesciences Corporation Information
6.3.2 Nectar Lifesciences Description and Business Overview
6.3.3 Nectar Lifesciences Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nectar Lifesciences Ceftriaxone Sodium Product Portfolio
6.3.5 Nectar Lifesciences Recent Developments/Updates
6.4 Kelun
6.4.1 Kelun Corporation Information
6.4.2 Kelun Description and Business Overview
6.4.3 Kelun Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kelun Ceftriaxone Sodium Product Portfolio
6.4.5 Kelun Recent Developments/Updates
6.5 United Laboratories
6.5.1 United Laboratories Corporation Information
6.5.2 United Laboratories Description and Business Overview
6.5.3 United Laboratories Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 United Laboratories Ceftriaxone Sodium Product Portfolio
6.5.5 United Laboratories Recent Developments/Updates
6.6 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aurobindo Pharma Ceftriaxone Sodium Product Portfolio
6.6.5 Aurobindo Pharma Recent Developments/Updates
6.7 Orchid Pharma
6.6.1 Orchid Pharma Corporation Information
6.6.2 Orchid Pharma Description and Business Overview
6.6.3 Orchid Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Orchid Pharma Ceftriaxone Sodium Product Portfolio
6.7.5 Orchid Pharma Recent Developments/Updates
6.8 Medya Pharma
6.8.1 Medya Pharma Corporation Information
6.8.2 Medya Pharma Description and Business Overview
6.8.3 Medya Pharma Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medya Pharma Ceftriaxone Sodium Product Portfolio
6.8.5 Medya Pharma Recent Developments/Updates
6.9 REYOUNG
6.9.1 REYOUNG Corporation Information
6.9.2 REYOUNG Description and Business Overview
6.9.3 REYOUNG Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 REYOUNG Ceftriaxone Sodium Product Portfolio
6.9.5 REYOUNG Recent Developments/Updates
6.10 LKPC
6.10.1 LKPC Corporation Information
6.10.2 LKPC Description and Business Overview
6.10.3 LKPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.10.4 LKPC Ceftriaxone Sodium Product Portfolio
6.10.5 LKPC Recent Developments/Updates
6.11 ACS Dobfar
6.11.1 ACS Dobfar Corporation Information
6.11.2 ACS Dobfar Ceftriaxone Sodium Description and Business Overview
6.11.3 ACS Dobfar Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ACS Dobfar Ceftriaxone Sodium Product Portfolio
6.11.5 ACS Dobfar Recent Developments/Updates
6.12 NCPC
6.12.1 NCPC Corporation Information
6.12.2 NCPC Ceftriaxone Sodium Description and Business Overview
6.12.3 NCPC Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NCPC Ceftriaxone Sodium Product Portfolio
6.12.5 NCPC Recent Developments/Updates
6.13 Dawnrays
6.13.1 Dawnrays Corporation Information
6.13.2 Dawnrays Ceftriaxone Sodium Description and Business Overview
6.13.3 Dawnrays Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dawnrays Ceftriaxone Sodium Product Portfolio
6.13.5 Dawnrays Recent Developments/Updates
6.14 Kopran
6.14.1 Kopran Corporation Information
6.14.2 Kopran Ceftriaxone Sodium Description and Business Overview
6.14.3 Kopran Ceftriaxone Sodium Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Kopran Ceftriaxone Sodium Product Portfolio
6.14.5 Kopran Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ceftriaxone Sodium Industry Chain Analysis
7.2 Ceftriaxone Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ceftriaxone Sodium Production Mode & Process
7.4 Ceftriaxone Sodium Sales and Marketing
7.4.1 Ceftriaxone Sodium Sales Channels
7.4.2 Ceftriaxone Sodium Distributors
7.5 Ceftriaxone Sodium Customers
8 Ceftriaxone Sodium Market Dynamics
8.1 Ceftriaxone Sodium Industry Trends
8.2 Ceftriaxone Sodium Market Drivers
8.3 Ceftriaxone Sodium Market Challenges
8.4 Ceftriaxone Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Ceftriaxone Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Ceftriaxone Sodium Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Ceftriaxone Sodium Market Competitive Situation by Manufacturers in 2023
Table 4. Global Ceftriaxone Sodium Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Ceftriaxone Sodium Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Ceftriaxone Sodium Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Ceftriaxone Sodium Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Ceftriaxone Sodium Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Ceftriaxone Sodium, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ceftriaxone Sodium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ceftriaxone Sodium, Product Type & Application
Table 12. Global Key Manufacturers of Ceftriaxone Sodium, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ceftriaxone Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ceftriaxone Sodium as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ceftriaxone Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Ceftriaxone Sodium Sales by Region (2019-2024) & (MT)
Table 18. Global Ceftriaxone Sodium Sales Market Share by Region (2019-2024)
Table 19. Global Ceftriaxone Sodium Sales by Region (2025-2030) & (MT)
Table 20. Global Ceftriaxone Sodium Sales Market Share by Region (2025-2030)
Table 21. Global Ceftriaxone Sodium Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Ceftriaxone Sodium Revenue Market Share by Region (2019-2024)
Table 23. Global Ceftriaxone Sodium Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Ceftriaxone Sodium Revenue Market Share by Region (2025-2030)
Table 25. North America Ceftriaxone Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Ceftriaxone Sodium Sales by Country (2019-2024) & (MT)
Table 27. North America Ceftriaxone Sodium Sales by Country (2025-2030) & (MT)
Table 28. North America Ceftriaxone Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Ceftriaxone Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Ceftriaxone Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Ceftriaxone Sodium Sales by Country (2019-2024) & (MT)
Table 32. Europe Ceftriaxone Sodium Sales by Country (2025-2030) & (MT)
Table 33. Europe Ceftriaxone Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Ceftriaxone Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Ceftriaxone Sodium Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Ceftriaxone Sodium Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Ceftriaxone Sodium Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Ceftriaxone Sodium Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Ceftriaxone Sodium Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ceftriaxone Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Ceftriaxone Sodium Sales by Country (2019-2024) & (MT)
Table 42. Latin America Ceftriaxone Sodium Sales by Country (2025-2030) & (MT)
Table 43. Latin America Ceftriaxone Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ceftriaxone Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ceftriaxone Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Ceftriaxone Sodium Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Ceftriaxone Sodium Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Ceftriaxone Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Ceftriaxone Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Ceftriaxone Sodium Sales (MT) by Type (2019-2024)
Table 51. Global Ceftriaxone Sodium Sales (MT) by Type (2025-2030)
Table 52. Global Ceftriaxone Sodium Sales Market Share by Type (2019-2024)
Table 53. Global Ceftriaxone Sodium Sales Market Share by Type (2025-2030)
Table 54. Global Ceftriaxone Sodium Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Ceftriaxone Sodium Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Ceftriaxone Sodium Revenue Market Share by Type (2019-2024)
Table 57. Global Ceftriaxone Sodium Revenue Market Share by Type (2025-2030)
Table 58. Global Ceftriaxone Sodium Price (USD/Kg) by Type (2019-2024)
Table 59. Global Ceftriaxone Sodium Price (USD/Kg) by Type (2025-2030)
Table 60. Global Ceftriaxone Sodium Sales (MT) by Application (2019-2024)
Table 61. Global Ceftriaxone Sodium Sales (MT) by Application (2025-2030)
Table 62. Global Ceftriaxone Sodium Sales Market Share by Application (2019-2024)
Table 63. Global Ceftriaxone Sodium Sales Market Share by Application (2025-2030)
Table 64. Global Ceftriaxone Sodium Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Ceftriaxone Sodium Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Ceftriaxone Sodium Revenue Market Share by Application (2019-2024)
Table 67. Global Ceftriaxone Sodium Revenue Market Share by Application (2025-2030)
Table 68. Global Ceftriaxone Sodium Price (USD/Kg) by Application (2019-2024)
Table 69. Global Ceftriaxone Sodium Price (USD/Kg) by Application (2025-2030)
Table 70. Shandong Ruiying Corporation Information
Table 71. Shandong Ruiying Description and Business Overview
Table 72. Shandong Ruiying Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Shandong Ruiying Ceftriaxone Sodium Product
Table 74. Shandong Ruiying Recent Developments/Updates
Table 75. Qilu Antibiotics Corporation Information
Table 76. Qilu Antibiotics Description and Business Overview
Table 77. Qilu Antibiotics Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Qilu Antibiotics Ceftriaxone Sodium Product
Table 79. Qilu Antibiotics Recent Developments/Updates
Table 80. Nectar Lifesciences Corporation Information
Table 81. Nectar Lifesciences Description and Business Overview
Table 82. Nectar Lifesciences Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Nectar Lifesciences Ceftriaxone Sodium Product
Table 84. Nectar Lifesciences Recent Developments/Updates
Table 85. Kelun Corporation Information
Table 86. Kelun Description and Business Overview
Table 87. Kelun Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Kelun Ceftriaxone Sodium Product
Table 89. Kelun Recent Developments/Updates
Table 90. United Laboratories Corporation Information
Table 91. United Laboratories Description and Business Overview
Table 92. United Laboratories Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. United Laboratories Ceftriaxone Sodium Product
Table 94. United Laboratories Recent Developments/Updates
Table 95. Aurobindo Pharma Corporation Information
Table 96. Aurobindo Pharma Description and Business Overview
Table 97. Aurobindo Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. Aurobindo Pharma Ceftriaxone Sodium Product
Table 99. Aurobindo Pharma Recent Developments/Updates
Table 100. Orchid Pharma Corporation Information
Table 101. Orchid Pharma Description and Business Overview
Table 102. Orchid Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Orchid Pharma Ceftriaxone Sodium Product
Table 104. Orchid Pharma Recent Developments/Updates
Table 105. Medya Pharma Corporation Information
Table 106. Medya Pharma Description and Business Overview
Table 107. Medya Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Medya Pharma Ceftriaxone Sodium Product
Table 109. Medya Pharma Recent Developments/Updates
Table 110. REYOUNG Corporation Information
Table 111. REYOUNG Description and Business Overview
Table 112. REYOUNG Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 113. REYOUNG Ceftriaxone Sodium Product
Table 114. REYOUNG Recent Developments/Updates
Table 115. LKPC Corporation Information
Table 116. LKPC Description and Business Overview
Table 117. LKPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 118. LKPC Ceftriaxone Sodium Product
Table 119. LKPC Recent Developments/Updates
Table 120. ACS Dobfar Corporation Information
Table 121. ACS Dobfar Description and Business Overview
Table 122. ACS Dobfar Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 123. ACS Dobfar Ceftriaxone Sodium Product
Table 124. ACS Dobfar Recent Developments/Updates
Table 125. NCPC Corporation Information
Table 126. NCPC Description and Business Overview
Table 127. NCPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 128. NCPC Ceftriaxone Sodium Product
Table 129. NCPC Recent Developments/Updates
Table 130. Dawnrays Corporation Information
Table 131. Dawnrays Description and Business Overview
Table 132. Dawnrays Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 133. Dawnrays Ceftriaxone Sodium Product
Table 134. Dawnrays Recent Developments/Updates
Table 135. Kopran Corporation Information
Table 136. Kopran Description and Business Overview
Table 137. Kopran Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 138. Kopran Ceftriaxone Sodium Product
Table 139. Kopran Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Ceftriaxone Sodium Distributors List
Table 143. Ceftriaxone Sodium Customers List
Table 144. Ceftriaxone Sodium Market Trends
Table 145. Ceftriaxone Sodium Market Drivers
Table 146. Ceftriaxone Sodium Market Challenges
Table 147. Ceftriaxone Sodium Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ceftriaxone Sodium
Figure 2. Global Ceftriaxone Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Ceftriaxone Sodium Market Share by Type in 2023 & 2030
Figure 4. ChP Product Picture
Figure 5. USP Product Picture
Figure 6. EP Product Picture
Figure 7. Global Ceftriaxone Sodium Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Ceftriaxone Sodium Market Share by Application in 2023 & 2030
Figure 9. Single Injection
Figure 10. Compound Injection
Figure 11. Global Ceftriaxone Sodium Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Ceftriaxone Sodium Market Size (2019-2030) & (US$ Million)
Figure 13. Global Ceftriaxone Sodium Sales (2019-2030) & (MT)
Figure 14. Global Ceftriaxone Sodium Average Price (USD/Kg) & (2019-2030)
Figure 15. Ceftriaxone Sodium Report Years Considered
Figure 16. Ceftriaxone Sodium Sales Share by Manufacturers in 2023
Figure 17. Global Ceftriaxone Sodium Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Ceftriaxone Sodium Players: Market Share by Revenue in 2023
Figure 19. Ceftriaxone Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Ceftriaxone Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Ceftriaxone Sodium Sales Market Share by Country (2019-2030)
Figure 22. North America Ceftriaxone Sodium Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Ceftriaxone Sodium Sales Market Share by Country (2019-2030)
Figure 26. Europe Ceftriaxone Sodium Revenue Market Share by Country (2019-2030)
Figure 27. Germany Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Ceftriaxone Sodium Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Ceftriaxone Sodium Revenue Market Share by Region (2019-2030)
Figure 34. China Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Ceftriaxone Sodium Sales Market Share by Country (2019-2030)
Figure 45. Latin America Ceftriaxone Sodium Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Ceftriaxone Sodium Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Ceftriaxone Sodium Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Ceftriaxone Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Ceftriaxone Sodium by Type (2019-2030)
Figure 55. Global Revenue Market Share of Ceftriaxone Sodium by Type (2019-2030)
Figure 56. Global Ceftriaxone Sodium Price (USD/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of Ceftriaxone Sodium by Application (2019-2030)
Figure 58. Global Revenue Market Share of Ceftriaxone Sodium by Application (2019-2030)
Figure 59. Global Ceftriaxone Sodium Price (USD/Kg) by Application (2019-2030)
Figure 60. Ceftriaxone Sodium Value Chain
Figure 61. Ceftriaxone Sodium Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
